Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Prakash Bhakuni"'
Autor:
Satish Bansal, Prakash Bhakuni, Hema Malini Aiyer, Sarita Rani Jaiswal, Mayank Soni, Suparno Chakrabarti
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:1469-1476
The major hindrances to the success of a haploidentical hematopoietic cell transplantation for hemoglobinopathies are graft failure, early post-transplant hemophagocytic syndrome (PTHPS), and graft-versus-host disease (GVHD). Following the successful
Autor:
Sarita Rani Jaiswal, Prakash Bhakuni, Suparno Chakrabarti, Aditi Chakrabarti, Hema Malini Aiyar, Gitali Bhagwati
Publikováno v:
Transplantation. 104:e23-e30
BACKGROUND The impact of newer approaches to haploidentical transplantation on Epstein-Barr virus (EBV) is largely unknown. METHODS We prospectively evaluated the incidence of EBV reactivation and its impact on transplantation outcomes in 71 patients
Autor:
Sneh Bhargava, Suparno Chakrabarti, Prakash Bhakuni, Hema Malini Aiyer, Sarita Rani Jaiswal, Satish Bansal
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e430-e435
Autor:
Aditi Chakrabarti, Aby Joy, Sarita Rani Jaiswal, Prakash Bhakuni, Suparno Chakrabarti, Gitali Bhagwati
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:1621-1628
We prospectively studied the impact of preemptive granulocyte infusions (pGIs) in 69 patients colonized with carbapenem-resistant gram-negative bacteria (CRGNB) undergoing haploidentical hematopoietic cell transplantation (HCT) compared with a previo
Autor:
Sarita Rani Jaiswal, Prakash Bhakuni, Atul Thatai, Mahesh Gupta, Suparno Chakrabarti, Mayank Soni
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation SocietyREFERENCES. 23(2)
Direct Acting Antivirals (DAA) have changed the landscape of hepatitis C virus (HCV) infection with high cure rates across genotypes. However, the use of these agents in the setting of allogeneic hematopoietic cell transplantation (HCT) has been limi
Autor:
Hema Malini Aiyer, Aditi Chakrabarti, Gitali Bhagawati, Sarita Rani Jaiswal, Prakash Bhakuni, Mayank Soni, Rishabh Raj Jaiswal, Suparno Chakrabarti, Navneet Sharma
Publikováno v:
Bone marrow transplantation. 56(1)
CTLA4Ig has a unique property to spare or even potentiate natural killer (NK) cell-mediated cytotoxicity, whilst inhibiting T cell activation. We explored the efficacy of prophylactic DLI following CTLA4Ig (CTLA4Ig-DLI group, n = 75), compared to con
Autor:
Sarita Rani Jaiswal, Nisha Murli, Aby Joy, Aditi Chakrabarti, Prakash Bhakuni, Ashok Rajoreya, Suparno Chakrabarti
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:2025-2033
To understand the phenomenon of early alloreactivity (EA) in younger children undergoing post-transplantation cyclophosphamide (PTCy)-based haploidentical transplantation, we studied the graft composition and the immune reconstitution in 32 consecuti
Autor:
Aby Joy, Priyanka Bharadwaj, Sarita Rani Jaiswal, Murugayan Nedunchezian, Nisha Murli, Suparno Chakrabarti, Shamsur Zaman, Prakash Bhakuni
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:542-548
We conducted a prospective study on T and natural killer (NK) cell subset composition of graft and transplant outcomes in T cell–replete haploidentical transplantation with a single dose of subcutaneous plerixafor (Px) added to granulocyte colony-s
Autor:
Sneh Bhargava, Priyanka Bharadwaj, Satish Bansal, Sarita Rani Jaiswal, Suparno Chakrabarti, Shamsuz Zaman, Prakash Bhakuni
Publikováno v:
Transplant Immunology. :54-59
We conducted a pilot study employing extended T cell costimulation blockade (COSBL) with Abatacept along with sirolimus and post-transplantation cyclophosphamide (PTCy) in 10 patients (median age 12) with severe aplastic anemia (SAA). Nine patients e
Autor:
Sarita Rani Jaiswal, Paul O'Donnell, Shamsur Zaman, Prakash Bhakuni, Murugaiyan Nedunchezhian, Aditi Chakrabarti, Kanika Sharma, Sheh Rawat, Margoob Ahmed, Suparno Chakrabarti
Publikováno v:
Cytotherapy. 19:531-542
We conducted a pilot study on the feasibility of CD56-enriched donor cell infusion after post-transplantation cyclophosphamide (PTCy) for 10 patients with advanced myeloid malignancies undergoing haploidentical peripheral blood stem cell transplantat